ARKK vs IBB
ARK Innovation ETF vs iShares Biotechnology ETF
ARKK$79.58
ARK Innovation ETF
Active disruptive-innovation strategy.
Expense: 0.75%Yield: 0.00%
IBB$217.75
iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense: 0.44%Yield: 0.16%
Quick take
- • IBB has the lower expense ratio at 0.44% vs 0.75% for ARKK.
- • IBB pays a higher dividend yield (0.16%).
Side-by-side metrics
| Metric | ARKK | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.44% |
Dividend yield Trailing 12-month yield. | 0.00% | 0.16% |
AUM Assets under management — bigger funds are typically more liquid. | $6.12B | $11.50B |
YTD return | 2.68% | 30.22% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.45 | 0.60 |
P/E ratio | 51.36 | 25.48 |
Last price | $79.58 | $217.75 |
Inception | — | — |
Issuer | ARK | iShares |
ARKK top holdings
Top holdings · ARKK
| TSLA | Tesla Inc | 10.65% |
| SPCX | Space Exploration Technologies Corp Class A | 6.13% |
| TEM | Tempus AI Inc Class A common stock | 5.61% |
| CRCL | Circle Internet Group Inc Ordinary Shares - Class A | 4.68% |
| CRSP | CRISPR Therapeutics AG | 4.44% |
| COIN | Coinbase Global Inc Ordinary Shares - Class A | 3.95% |
| TWST | Twist Bioscience Corp | 3.56% |
| SHOP | Shopify Inc Registered Shs -A- Subord Vtg | 3.11% |
| NVDA | NVIDIA Corp | 2.93% |
Sector breakdown · ARKK
Consumer Cyclical13.8%
Technology25.3%
Communication Services3.1%
Financial Services14.8%
Industrials12.2%
Healthcare30.8%
IBB top holdings
Top holdings · IBB
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
Sector breakdown · IBB
Healthcare100.0%
About ARKK
ARKK (ARK Innovation ETF) is Active disruptive-innovation strategy. Managed by ARK, the fund carries $6.1B in assets under management, an expense ratio of 0.75%. Its largest holding is Tesla Inc (TSLA), which represents 10.7% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 13.8%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.